Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATXN1 antisense RNA 1 (ATXN1-AS1, also known as AL137003.1) is a long non-coding RNA transcribed antisense to the ATXN1 gene. While the ATXN1 gene encodes ataxin-1, a nuclear protein implicated in neurodegenerative diseases including spinocerebellar ataxia type 1 (SCA1)[5][7], there is currently no published evidence of a functional, therapeutic, or clinical role for its antisense transcript ATXN1-AS1 in the literature or major genetic databases. Most available scientific and medical information pertains to the protein-coding ATXN1 gene, not the ATXN1-AS1 lncRNA[1][2][3][4][5][6][7][8]. If you require information about the protein product (ataxin-1, encoded by ATXN1), there is considerably more disease and drug development research available. As of this response, however, ATXN1-AS1 itself should be considered a poorly characterized lncRNA with no established function, target profile, or clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATXN1 antisense RNA 1 (ATXN1-AS1).